Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality.
about
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphodiesterase type-5 inhib ...... uction in all-cause mortality.
@en
Phosphodiesterase type-5 inhib ...... uction in all-cause mortality.
@nl
type
label
Phosphodiesterase type-5 inhib ...... uction in all-cause mortality.
@en
Phosphodiesterase type-5 inhib ...... uction in all-cause mortality.
@nl
prefLabel
Phosphodiesterase type-5 inhib ...... uction in all-cause mortality.
@en
Phosphodiesterase type-5 inhib ...... uction in all-cause mortality.
@nl
P2093
P2860
P50
P1433
P1476
Phosphodiesterase type-5 inhib ...... duction in all-cause mortality
@en
P2093
Adrian H Heald
Andrew W Trafford
Geoff Hackett
Kazem Rahimi
Mark Woodward
Mike Kirby
P2860
P304
P356
10.1136/HEARTJNL-2015-309223
P407
P577
2016-07-26T00:00:00Z